CYBERONICS' NCP DEVICE FOR EPILEPSY INITIAL COMMERCIAL IMPLANT SET FOR JULY 24; FDA APPROVAL COMES LESS THAN THREE WEEKS AFTER PANEL REVIEW
This article was originally published in The Gray Sheet
Executive Summary
The first commercial implant of Cyberonics' NeuroCybernetic Prosthesis (NCP) system is slated for July 24 following FDA's July 16 approval of a premarket approval application for the implantable vagus nerve stimulator for treating epilepsy.